Two groups of bullous pemphigoid antigens are identified by affinity-purified antibodies
- PMID: 2182719
- DOI: 10.1111/1523-1747.ep12876194
Two groups of bullous pemphigoid antigens are identified by affinity-purified antibodies
Abstract
The bullous pemphigoid antigen was originally described as a 240-kD protein extracted from human epidermis, but a subsequent report has described patients' sera which react with epidermal proteins of molecular masses 240, 200, 180, 97, and 77 kD. We have evaluated the heterogeneity of the pemphigoid antigens identified by the sera of 10 patients with clinically typical bullous pemphigoid. We used indirect immunofluorescence and Western immunoblots of epidermal extracts prepared from epidermis separated by either 1 M salt or 20 mM EDTA to characterize the reactivity of both crude sera and affinity-purified antibodies. Affinity purification of antibodies was performed with either normal human epidermis or protein bands blotted onto nitrocellulose as immunoabsorbents. The anti-basement membrane antibody titers determined by indirect immunofluorescence on the saline- and EDTA-separated epidermis were identical. Despite this, Western blots of extracts prepared from EDTA-separated epidermis demonstrated greater amounts of the 240-kD antigen than saline split skin. Multiple antigens were recognized in epidermal extracts on Western blots by most crude BP sera, including bands at 240, 200, 160, and 100 kD. Different sera reacted with these antigens with a markedly different intensity, falling into two major groups, those bearing antibodies to the 240-200-kD antigens and those with antibodies to the 160-100-kD components. When epidermis was used as a substrate for affinity purification of bullous pemphigoid antibodies, the eluted antibodies reacted with multiple bands on Western blots, demonstrating the reactivity of anti-basement membrane zone antibodies with multiple proteins. Antibodies eluted from several individual bands of immunoblots were found to react with the basement membrane on indirect immunofluorescence. When these nitrocellulose-purified antibodies were reapplied to Western blots, they cross-reacted within two groups, the 240-200 kD antigens and the 160-100 kD antigens. We conclude that pemphigoid antigens are best demonstrated when EDTA-split skin is used for extraction and that different pemphigoid sera may contain antibodies to two separate groups of basement membrane zone antigens.
Comment in
-
Heterogeneity of the bullous pemphigoid antigen: what is true and what is artifact?J Invest Dermatol. 1991 Apr;96(4):527-9. doi: 10.1111/1523-1747.ep12470243. J Invest Dermatol. 1991. PMID: 1958246 No abstract available.
Similar articles
-
Recent advances on the 180-kDa epidermal antigen in autoimmune subepidermal bullous skin diseases.Springer Semin Immunopathol. 1992;13(3-4):401-12. doi: 10.1007/BF00200537. Springer Semin Immunopathol. 1992. PMID: 1411905 Review.
-
Identification of the cutaneous basement membrane zone antigen and isolation of antibody in linear immunoglobulin A bullous dermatosis.J Clin Invest. 1990 Mar;85(3):812-20. doi: 10.1172/JCI114508. J Clin Invest. 1990. PMID: 2107211 Free PMC article.
-
Identification of a 160-kD molecule as a component of the basement membrane zone and as a minor bullous pemphigoid antigen.J Invest Dermatol. 1990 Jun;94(6):817-21. doi: 10.1111/1523-1747.ep12874675. J Invest Dermatol. 1990. PMID: 1693941
-
Identification of a basement membrane zone antigen reactive with circulating IgA antibody in ocular cicatricial pemphigoid.J Invest Dermatol. 1993 Oct;101(4):619-23. doi: 10.1111/1523-1747.ep12366078. J Invest Dermatol. 1993. PMID: 8409534
-
Childhood localized vulvar pemphigoid is a true variant of bullous pemphigoid.Arch Dermatol. 1992 Jun;128(6):807-10. Arch Dermatol. 1992. PMID: 1599268 Review.
Cited by
-
Recent advances on the 180-kDa epidermal antigen in autoimmune subepidermal bullous skin diseases.Springer Semin Immunopathol. 1992;13(3-4):401-12. doi: 10.1007/BF00200537. Springer Semin Immunopathol. 1992. PMID: 1411905 Review.
-
Targeting type 2 inflammation in bullous pemphigoid: current and emerging therapeutic approaches.Front Med (Lausanne). 2023 Aug 8;10:1196946. doi: 10.3389/fmed.2023.1196946. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37614956 Free PMC article. Review.
-
New Insights Into the Pathogenesis of Bullous Pemphigoid: 2019 Update.Front Immunol. 2019 Jul 2;10:1506. doi: 10.3389/fimmu.2019.01506. eCollection 2019. Front Immunol. 2019. PMID: 31312206 Free PMC article. Review.
-
Human autoantibodies against the 230-kD bullous pemphigoid antigen (BPAG1) bind only to the intracellular domain of the hemidesmosome, whereas those against the 180-kD bullous pemphigoid antigen (BPAG2) bind along the plasma membrane of the hemidesmosome in normal human and swine skin.J Clin Invest. 1993 Apr;91(4):1608-15. doi: 10.1172/JCI116368. J Clin Invest. 1993. PMID: 7682575 Free PMC article.
-
Bullous Pemphigoid and Epidemiological Patterns in Northern Greece: Insights from an 8-Year Observational Study.Dermatol Pract Concept. 2025 Apr 1;15(2):4852. doi: 10.5826/dpc.1502a4852. Dermatol Pract Concept. 2025. PMID: 40401859 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical